Treatment of ZIP9-associated diseases with tetrapeptides

Kurzbeschreibung:
Application fields of tetrapeptides, such as the tetrapeptide "isoleucine-alanine-proline-glycine", are the treatment of various diseases in which ZIP9-expressing cells are involved, such as osteoporosis and muscle atrophy, as well as other disease patterns.

PDF-Dokument

Kontakt:
TransMIT GmbH
Kerkrader Str. 3
35394 Gießen
Telefon: +49 (6 41) 9 43 64 - 0
E-Mail: patente@transmit.de